TILT Biotherapeutics (private company)

See something wrong or missing? Let us know
Business model:
Key People:
Akseli Hemminki

Total investments received (USD) - 10.63M

TILT Biotherapeutics Ltd is a preclinical stage company working in the field of cancer immunotherapy. TILT aims to translate its unique approach into clinical trials.

The company’s patented technology involves utilization of oncolytic viruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR) and checkpoint inhibiting antibody therapy.

The TILT approach has the potential to achieve similar results in CAR therapy of  solid tumors as currently achieved for CD19+ hematological tumors.

Companies with similar profile to TILT Biotherapeutics:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)